Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Katerina Gemenetzi
Observed names:
Gemenetzi, Katerina,
K Gemenetzi
Observed institutions:
Democritus University of Thrace,
Centre for Research and Technology Hellas,
University Hospital of Alexandroupolis
ORCID:
0000-0002-1331-3925
Observed ORCID:
0000-0002-1331-3925
OpenAlex ID:
A5085697238
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL
2020
·
Andreas Agathangelidis
, Anastasia Chatzidimitriou
, et al.
·
Blood
·
133
PDF
Restrictions in the T-cell repertoire of chronic lymphocytic leukemia: high-throughput immunoprofiling supports selection by shared antigenic elements
2016
·
A Vardi
, E Vlachonikola
, et al.
·
Leukemia
·
56
Higher-order immunoglobulin repertoire restrictions in CLL: the illustrative case of stereotyped subsets 2 and 169
2020
·
Katerina Gemenetzi
, Fotis Psomopoulos
, et al.
·
Blood
·
33
B Cell Receptor Immunogenetics in B Cell Lymphomas: Immunoglobulin Genes as Key to Ontogeny and Clinical Decision Making
2020
·
Katerina Gemenetzi
, Andreas Agathangelidis
, et al.
·
Frontiers in Oncology
·
27
PDF
T-Cell Dynamics in Chronic Lymphocytic Leukemia under Different Treatment Modalities
2020
·
Anna Vardi
, Elisavet Vlachonikola
, et al.
·
Clinical Cancer Research
·
25
Distinctive Signaling Profiles With Distinct Biological and Clinical Implications in Aggressive CLL Subsets With Stereotyped B-Cell Receptor Immunoglobulin
2021
·
Marina Gerousi
, Stamatia Laidou
, et al.
·
Frontiers in Oncology
·
17
PDF
TRIP - T cell receptor/immunoglobulin profiler
2020
·
Maria Th. Kotouza
, Katerina Gemenetzi
, et al.
·
BMC Bioinformatics
·
17
PDF
Increased frequency of the single nucleotide polymorphism of the DARC / ACKR1 gene associated with ethnic neutropenia in a cohort of European patients with chronic idiopathic neutropenia
2020
·
Irene Fragiadaki
, Stavros Papadakis
, et al.
·
American Journal of Hematology
·
16
PDF
Cytotoxic T cells in chronic idiopathic neutropenia express restricted antigen receptors
2017
·
Semeli Mastrodemou
, Evangelia Stalika
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
7
Discordances between Immunofixation (IFx) and Minimal Residual Disease (MRD) Assessment with Next-Generation Flow (NGF) and Sequencing (NGS) in Patients (Pts) with Multiple Myeloma (MM): Clinical and Pathogenic Significance
2020
·
Sara Rodríguez
, Ibai Goicoechea
, et al.
·
Blood
·
5
High-Throughput T Cell Receptor (TR) Repertoire Analysis of Virus-Specific T Cells: Implications for T Cell Immunotherapy and Viral Infection Risk Stratification
2018
·
Chrysi Galigalidou
, Anastasia Papadopoulou
, et al.
·
Blood
·
5
Remarkable Functional Constraints on the Antigen Receptors of CLL Stereotyped Subset #2: High-Throughput Immunogenetic Evidence
2018
·
Katerina Gemenetzi
, Andreas Agathangelidis
, et al.
·
Blood
·
5
Tp53gene p72R polymorphism in chronic lymphocytic leukemia: incidence and clinical significance amongst cases with unmutated immunoglobulin receptors
2016
·
Katerina Gemenetzi
, Chrysi Galigalidou
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
4
VH CDR3-Focused Somatic Hypermutation in CLL IGHV-IGHD-IGHJ Gene Rearrangements with 100% IGHV Germline Identity
2019
·
Katerina Gemenetzi
, Andreas Agathangelidis
, et al.
·
Blood
·
3
Evidence for Epitope-Specific T Cell Responses in HIV-Associated Non Neoplastic Lymphadenopathy: High-Throughput Immunogenetic Evidence
2018
·
Katerina Gemenetzi
, Evangelia Stalika
, et al.
·
Blood
·
3
Distinct Immunogenetic Signatures in IgA Versus IgG Multiple Myeloma
2016
·
Katerina Gemenetzi
, Andreas Agathangelidis
, et al.
·
Blood
·
3
The Pathogenesis of Multiple Myeloma (MM) Is Preceded By Mutated Lymphopoiesis and B Cell Oligoclonality That Persist in Patients with Negative Minimal Residual Disease (MRD)
2019
·
Sara Rodríguez
, Noemi Puig
, et al.
·
Blood
·
2
Higher Order Restrictions of the Immunoglobulin Repertoire in CLL: The Illustrative Case of Stereotyped Subsets #2 and #169
2019
·
Katerina Gemenetzi
, Andreas Agathangelidis
, et al.
·
Blood
·
1
Data from T-Cell Dynamics in Chronic Lymphocytic Leukemia under Different Treatment Modalities
2023
·
Anna Vardi
, Elisavet Vlachonikola
, et al.
Data from T-Cell Dynamics in Chronic Lymphocytic Leukemia under Different Treatment Modalities
2023
·
Anna Vardi
, Elisavet Vlachonikola
, et al.
Supplementary Data from T-Cell Dynamics in Chronic Lymphocytic Leukemia under Different Treatment Modalities
2023
·
Anna Vardi
, Elisavet Vlachonikola
, et al.
PDF
Supplementary Data from T-Cell Dynamics in Chronic Lymphocytic Leukemia under Different Treatment Modalities
2023
·
Anna Vardi
, Elisavet Vlachonikola
, et al.
Longitudinal High-Throughput T Cell Repertoire Profiling of Chronic Lymphocytic Leukemia Patients Under Different Types of Treatment: Implications for Combination Strategies
2018
·
Anna Vardi
, Elisavet Vlachonikola
, et al.
·
Blood
Differential Impact of Signaling Inhibitor Treatment Versus Standard Chemoimmunotherapy on Chronic Lymphocytic Leukemia T Cells: Clinical Implications
2017
·
Anna Vardi
, Elisavet Vlachonikola
, et al.
·
Blood
Chronic Idiopathic Neutropenia does not Display Frequent Stat3 Mutations : Implications for Differential Diagnosis from Other Clinical Syndromes with T-Cell-Mediated Suppression of Hematopoiesis
2014
·
Evangelia Stalika
, Irene Mavroudi
, et al.
Show more works
View as search
Works count:
26
Citation count:
363
H-index:
8
I10-index:
8
Year
Topic
Type
